Pasithea Therapeutics (KTTA) Total Current Liabilities (2021 - 2024)
Historic Total Current Liabilities for Pasithea Therapeutics (KTTA) over the last 4 years, with Q3 2024 value amounting to $660397.0.
- Pasithea Therapeutics' Total Current Liabilities fell 6768.98% to $660397.0 in Q3 2024 from the same period last year, while for Sep 2024 it was $660397.0, marking a year-over-year decrease of 6768.98%. This contributed to the annual value of $2.6 million for FY2023, which is 4028.51% up from last year.
- As of Q3 2024, Pasithea Therapeutics' Total Current Liabilities stood at $660397.0, which was down 6768.98% from $1.4 million recorded in Q2 2024.
- Pasithea Therapeutics' Total Current Liabilities' 5-year high stood at $2.6 million during Q4 2023, with a 5-year trough of $433684.0 in Q1 2022.
- Over the past 4 years, Pasithea Therapeutics' median Total Current Liabilities value was $1.5 million (recorded in 2022), while the average stood at $1.5 million.
- Per our database at Business Quant, Pasithea Therapeutics' Total Current Liabilities surged by 38933.32% in 2023 and then plummeted by 6768.98% in 2024.
- Over the past 4 years, Pasithea Therapeutics' Total Current Liabilities (Quarter) stood at $447280.0 in 2021, then soared by 319.79% to $1.9 million in 2022, then soared by 40.29% to $2.6 million in 2023, then tumbled by 74.93% to $660397.0 in 2024.
- Its Total Current Liabilities stands at $660397.0 for Q3 2024, versus $1.4 million for Q2 2024 and $2.5 million for Q1 2024.